< Weichung “Joe” Shih Ph.D. EOHSI Directory | EOHSI

Weichung “Joe” Shih Ph.D. » EOHSI Directory

A B C D E F G H I J K L M N O P R S T U W Y Z

Weichung “Joe” Shih Ph.D.

Professor and Chair of Biostatistics Rutgers University, School of Public HealthEOHSI – Environmental Epidemiology and Statistics
Work School of Public Health Room 216 683 Hoes Lane Piscataway NJ 08840 Work Phone: 732-235-6791
Photo of Weichung “Joe” Shih Ph.D.

Biographical Info

Dr. Shih is a member of the Editorial Boards of the Society for Clinical Trials, the Journal of Statistics in Biopharmaceutical Research, Statistics in Medicine, Statistica Sinica, and the Journal of Clinical Cancer Research.

Research Areas

  • Biometrics
  • Bioinformatics
  • Statistics

Scholarly Activities

  • 2002 Excellence in Teaching Award, The Student Government Association, School of Public Health
  • 1996 Elected American Statistical Association (ASA) Fellow

Recent Publications

  1. Silk, AW, Kaufman, HL, Curti, B, Mehnert, JM, Margolin, K, McDermott, D, Clark, J, Newman, J, Bommareddy, PK, Denzin, L et al.. High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma. Front Oncol. 2019;9 :1483. doi: 10.3389/fonc.2019.01483. PubMed PMID:31998643 PubMed Central PMC6965158
  2. Lin, Y, Shih, WJ, Lu, SE. Two-stage enrichment clinical trial design with adjustment for misclassification in predictive biomarkers. Stat Med. 2019;38 (29):5445-5469. doi: 10.1002/sim.8370. PubMed PMID:31621944 PubMed Central PMC6842057
  3. Portal, DE, Weiss, RE, Wojtowicz, M, Mansour, A, Monken, C, Mehnert, JM, Aisner, JA, Kane, M, Nishioka, J, Aisner, S et al.. Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. Cancer Gene Ther. 2019; :. doi: 10.1038/s41417-019-0112-z. PubMed PMID:31222182 PubMed Central PMC6923616
  4. Shen, M, Jiang, YZ, Wei, Y, Ell, B, Sheng, X, Esposito, M, Kang, J, Hang, X, Zheng, H, Rowicki, M et al.. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell. 2019;35 (1):64-80.e7. doi: 10.1016/j.ccell.2018.11.016. PubMed PMID:30612941
  5. Cannon, CP, McGuire, DK, Pratley, R, Dagogo-Jack, S, Mancuso, J, Huyck, S, Charbonnel, B, Shih, WJ, Gallo, S, Masiukiewicz, U et al.. Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). Am. Heart J. 2018;206 :11-23. doi: 10.1016/j.ahj.2018.08.016. PubMed PMID:30290289
  6. Song, M, Kumaran, MN, Gounder, M, Gibbon, DG, Nieves-Neira, W, Vaidya, A, Hellmann, M, Kane, MP, Buckley, B, Shih, W et al.. Phase I trial of selenium plus chemotherapy in gynecologic cancers. Gynecol. Oncol. 2018;150 (3):478-486. doi: 10.1016/j.ygyno.2018.07.001. PubMed PMID:30068487 PubMed Central PMC6154492
  7. Bak, MJ, Furmanski, P, Shan, NL, Lee, HJ, Bao, C, Lin, Y, Shih, WJ, Yang, CS, Suh, N. Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer. Carcinogenesis. 2018;39 (8):1045-1055. doi: 10.1093/carcin/bgy071. PubMed PMID:29846560 PubMed Central PMC6067126
  8. Dinizo, M, Shih, W, Kwon, YS, Eun, D, Reese, A, Giusto, L, Trabulsi, EJ, Yuh, B, Ruel, N, Marchalik, D et al.. Multi-institution analysis of racial disparity among African-American men eligible for prostate cancer active surveillance. Oncotarget. 2018;9 (30):21359-21365. doi: 10.18632/oncotarget.25103. PubMed PMID:29765545 PubMed Central PMC5940363
  9. Hegyi, T, Kleinfeld, A, Huber, A, Weinberger, B, Memon, N, Shih, W, Carayannopoulos, M, Oh, W. Unbound bilirubin measurements by a novel probe in preterm infants. J. Matern. Fetal. Neonatal. Med. 2019;32 (16):2721-2726. doi: 10.1080/14767058.2018.1448380. PubMed PMID:29504491 PubMed Central PMC6135709
  10. Mehnert, JM, Silk, AW, Lee, JH, Dudek, L, Jeong, BS, Li, J, Schenkel, JM, Sadimin, E, Kane, M, Lin, H et al.. A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma. Pigment Cell Melanoma Res. 2018;31 (4):534-540. doi: 10.1111/pcmr.12694. PubMed PMID:29453787 PubMed Central PMC6013351
Search PubMed
Categories: Faculty, Environmental Epidemiology and Statistics
Skip to toolbar